Investor Area

ICU Medical Technologies S.L. has developed KronoSafe System®, a device that allows temporary cardiac pacing with active-fixation leads.

  • Low rate of complications
  • Avoid ICU admission
  • Early rehabilitation
  • Allow Cardiac Stimulation at home
  • Short learning curve
  • Easy market entry

Number of current investors: 4

icu medical

ICU MEDICAL TECHNOLOGIES

ICU Medical Technologies S.L. is the Medical Device Company that has developed KronoSafe®. This System allows temporary cardiac pacing with active-fixation leads, adapting for external use the  definitive pacemaker generators and electrodes. According to current projections, it will be on sale by the end of 2022.

The increased safety and effectiveness provided by KronoSafe® allows the patient to be discharged from the Intensive Care Unit, freeing up necessary beds for other critical patients. In addition, it provides the safety needed to perform temporary cardiac pacing at home.

The initial investment round  will allow us to start sales at the European market, where more than 200,000 procedures per year are done. 

Now is the best moment to participate in the KronoSafe® Project.

MARKET

Temporary Cardiac Stimulation is a procedure performed 200,000 times a year in Europe, and more than 1,000,000 times a year worldwide.

USERS AND CUSTOMERS

Our users will be Intensive Care Physicians and Cardiologists in which we will reduce the complications of their patients using KronoSafe®.
Our customers will be the health systems, hospitals; to which we also provide financial savings: we will reduce the costs related to the treatment of complications and the hospital stay, liberating ICU beds for other patients.

INTELLECTUAL PROPERTY PROTECTION

At present, KronoSafe System® has a Spanish Patent and a favorable PCT report for all its claims. We have started the procedure  to expand our KronoSafe® protection in strategic countries such as the USA, China, Canada, India, Australia, Russia and Europe.

EXPERT ADVICE

The ICU Medical Technologies project has an Economic Viability Study carried out by an independent consultancy, supporting our projections.

Team

Ray Vicente

Ray Vicente

Founder and Chief Executive Officer (CEO)

Clara Gómez

Clara Gómez

COO (Chief Operations Officer) & Regulatory Affairs Manager

Ignacio Puig

Ignacio Puig

Chief Marketing Officer

TOTAL INVESTMENT ROUND:

TARGET

European Market

  • Staff 55% 55%
  • Production and Commercialization 27% 27%
  • World Intellectual Property Protection 14% 14%
  • Other expenses 4% 4%

REQUEST OUR INVESTMENT DOSSIER

Business Deck

Get Started

CONTACT

15 + 9 =

OFfice

Edificio Innova – Universidad Miguel Hernández de Elche 

Avenida de la Universidad s/n 

03202 Elche, Alicante

ICU Medical Technologies S.L. - Copyright 2020 - Legal Notice - Privacy Policy - Cookies Policy

Si continúas usando este sitio, aceptas el uso de cookies. + Info

Los ajustes de cookies en esta web están configurados para «permitir las cookies» y ofrecerte la mejor experiencia de navegación posible. Si sigues usando esta web sin cambiar tus ajustes de cookies o haces clic en «Aceptar», estarás dando tu consentimiento a esto.

Cerrar